5929 Results (Page 1 of 495)
All Market Research Reports
Romania Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Romania Liver Cancer Therapeutics market will reach a value of $31.6 Mn from $8.5 Mn in 2022, growing at a CAGR of 17.9 % during 2022-2030. Liver Cancer Therapeutics in Romania is dominated by a few domestic pharmaceutical companies such as Biofarm, Antibiotice and Fundeni Clinical Institute. The Liver Cancer Therapeutics market in Romania is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Romania Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
US Obesity Drugs Market Analysis
The US obesity drugs market is projected to grow from $1.2 Bn in 2022 to $5.2 Bn by 2030, registering a CAGR of 20.3% during the forecast period of 2022-30. There is increasing awareness of the health risks associated with obesity, including heart disease, diabetes, and high blood pressure. This is driving demand for effective treatments that can help reduce the risk of these conditions. Novo Nordisk, a Danish pharmaceutical company is a major player in the obesity drugs market, with a portfolio of products that includes Saxenda (liraglutide), an injectable drug approved for weight loss in adults with obesity.
US ENT Devices Market Analysis
The US ENT devices market is projected to grow from $9.7 Bn in 2022 to $13.1 Bn by 2030, registering a CAGR of 3.75% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. According to the National Institute on Deafness and Other Communication Disorders, approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. Some of the key players in the market include Cochlear Limited, William Demant Holding A/S, Medtronic plc, Stryker Corporation, and Olympus Corporation.
Poland Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Poland Liver Cancer Therapeutics market will reach a value of $64.1 Mn from $17 Mn in 2022, growing at a CAGR of 18.1 % during 2022-2030. Liver Cancer Therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma Biologics, Adamed Group and Celon Pharma. The Liver Cancer Therapeutics market in Poland is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Poland Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
US Diabetes Devices Market Analysis
The US diabetes devices market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. Some of the key trends in the US diabetes devices market include the development of more advanced glucose monitoring and insulin delivery technologies, the use of digital health platforms and apps to help patients manage their diabetes, and the shift towards value-based care models that prioritize patient outcomes and cost-effectiveness. The US diabetes devices market is highly competitive, with several major players dominating the market. Some of the key players in the market include Abbott Laboratories, Medtronic, Dexcom, Roche, and Insulet Corporation.
US Coronary Stents Market Analysis
The US coronary stents market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. The US coronary stents market is driven by several factors, including the high prevalence of coronary artery disease (CAD) in the US, advances in stent technology, and increasing demand for minimally invasive procedures. The market is highly competitive, with several major players such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic dominating the market. These companies invest heavily in research and development to develop innovative stent technologies that provide better outcomes for patients.
US Contraceptive Devices Market Analysis
The US contraceptive devices market is projected to grow from $5.4 Bn in 2022 to $8.6 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US contraceptive devices market is a growing and dynamic market that includes a range of products designed to prevent pregnancy. Bayer is a German multinational pharmaceutical company that manufactures a range of contraceptive products, including oral contraceptives and IUDs.
US Connected Healthcare Market Analysis
The US connected healthcare market is projected to grow from $28 Bn in 2022 to $182 Bn by 2030, registering a CAGR of 26.4% during the forecast period of 2022-30. The US Connected Healthcare market is highly competitive, with a wide range of companies offering products and services in this space. Major players include Apple, Google, Philips, and Samsung, as well as numerous startups and smaller companies. The widespread use of smartphones, tablets, and other mobile devices has led to the growth of mHealth technologies such as mobile health apps, wearables, and telehealth services, which enable patients to receive healthcare services remotely.
US Cardiac Surgery Instruments Market Analysis
The US cardiac surgery instruments market is projected to grow from $0.9 Bn in 2022 to $1.2 Bn by 2030, registering a CAGR of 4.6% during the forecast period of 2022-30. This growth is primarily due to an increasing number of cardiac surgeries, especially in the elderly population, and the adoption of advanced surgical instruments. The market is highly competitive, with several established players including B. Braun Melsungen AG, CONMED Corporation, Johnson & Johnson Services, Inc., Medline Industries, Inc., and Stryker Corporation. These companies offer a wide range of cardiac surgery instruments and compete on the basis of product quality, innovation, and pricing.
Nigeria Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Nigeria Liver Cancer Therapeutics market will reach a value of $10.3 Mn from $2.6 Mn in 2022, growing at a CAGR of 18.6 % during 2022-2030. Liver Cancer Therapeutics in Nigeria is dominated by a few domestic pharmaceutical companies such as Swiss Pharma Nigeria, Fidson Healthcare and Neimeth. The Liver Cancer Therapeutics market in Nigeria is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Nigeria Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
US Cardiac Monitoring Devices Market Analysis
The US cardiac monitoring device market is projected to grow from $12.1 Bn in 2022 to $15 Bn by 2030, registering a CAGR of 2.7% during the forecast period of 2022-30. The US cardiac monitoring device market is expected to continue growing as the demand for accurate and reliable Cardiac Monitoring devices increases. Medtronic is a leading medical device company that offers a range of cardiac monitoring devices, including implantable cardiac monitors, pacemakers, and defibrillators.
US Radiotherapy Market Analysis
The US radiotherapy market is projected to grow from $2.9 Bn in 2022 to $3.97 Bn by 2030, registering a CAGR of 4% during the forecast period of 2022-30. The market is primarily driven by factors such as increasing cancer prevalence, rising demand for non-invasive cancer treatments, and technological advancements in radiotherapy equipment. The US is one of the largest markets for radiotherapy globally, with a significant number of cancer treatment centers and a high level of investment in research and development. The key players in the US radiotherapy market include major medical device manufacturers and radiation therapy providers such as Varian Medical Systems, Elekta AB, Accuray Incorporated, and Siemens Healthineers.
Netherlands Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Netherlands Liver Cancer Therapeutics market will reach a value of $28.8 Mn from $7.6 Mn in 2022, growing at a CAGR of 18.1 % during 2022-2030. The Liver Cancer Therapeutics in the Netherlands is dominated by a few domestic pharmaceutical companies such as AM-Pharma, Kiadis Pharma and Galapagos. The Liver Cancer Therapeutics market in the Netherlands is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Netherlands Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
US Liver Diseases Therapeutics Market Analysis
The US liver disease therapeutics market is projected to grow from $9.7 Bn in 2022 to $13 Bn by 2030, registering a CAGR of 3.7% during the forecast period of 2022-30. Liver diseases such as hepatitis, liver cancer, and NAFLD are becoming increasingly prevalent in the US population, driving demand for effective treatments. Some of the key players operating in the US liver disease therapeutics market include Gilead Sciences, Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol-Myers Squibb, and Novartis AG. These companies are investing heavily in research and development to develop new and innovative treatments for liver disease and are expected to continue to drive the growth of the market in the coming years.
Mexico Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico Liver Cancer Therapeutics market will reach a value of $163.5 Mn from $44 Mn in 2022, growing at a CAGR of 17.9 % during 2022-2030. Liver Cancer Therapeutics in Mexico is dominated by a few domestic pharmaceutical companies such as Laboratorios PiSA, Liomont and Genomma Lab Internacional. The Liver Cancer Therapeutics market in Mexico is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Mexico Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
US Liver Cancer Therapeutics Market Analysis
The US liver cancer therapeutics market is projected to grow from $1.2 Bn in 2022 to $3.9 Bn by 2030, registering a CAGR of 15.6% during the forecast period of 2022-30. The market for liver cancer therapeutics in the US is driven by factors such as the increasing prevalence of liver cancer, the growing demand for effective treatment options, and advancements in technology and drug development. In addition, the increasing use of combination therapies, the development of targeted therapies, and the focus on personalized medicine are also contributing to the growth of this market. The major players operating in the US liver cancer therapeutics market include pharmaceutical companies such as Bristol-Myers Squibb, Bayer Healthcare, Pfizer Inc., Eisai Co., Ltd., and F. Hoffmann-La Roche AG.
Malaysia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Malaysia Liver Cancer Therapeutics market will reach a value of $17.5 Mn from $4.71 Mn in 2022, growing at a CAGR of 17.8% during 2022-2030. Liver Cancer Therapeutics in Malaysia is dominated by a few domestic pharmaceutical companies such as Pharmaniaga, Pantai Hospital and National Cancer Institute. The Liver Cancer Therapeutics market in Malaysia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Malaysia Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
US In Vitro Fertilisation (IVF) Service Market Analysis
The US In Vitro Fertilization (IVF) services market is projected to grow from $7.5 Bn in 2022 to $13.2 Bn by 2030, registering a CAGR of 7.3% during the forecast period of 2022-30. The market is expected to be driven by factors such as rising infertility rates, increasing awareness and acceptance of ART procedures, and the availability of advanced reproductive technologies. The major players in the US IVF Services market include companies such as Vitrolife AB, CooperSurgical Inc., Ferring Pharmaceuticals Inc., Irvine Scientific, Merck KGaA, and OvaScience Inc. These companies offer a range of IVF products and services, including fertility drugs, laboratory equipment, and diagnostic tests.
Kenya Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Kenya Liver Cancer Therapeutics market will reach a value of $8.1 Mn from $2.1 Mn in 2022, growing at a CAGR of 18.7 % during 2022-2030. Liver Cancer Therapeutics in Kenya is dominated by a few domestic pharmaceutical companies such as Cosmos Limited, Medisel and Hetero Labs. The Liver Cancer Therapeutics market in Kenya is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Kenya Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
US Infectious Disease Therapeutics Market Analysis
The US infectious disease therapeutics market is projected to grow from $50.3 Bn in 2022 to $60.6 Bn by 2030, registering a CAGR of 2.35% during the forecast period of 2022-30. Antibiotics are one of the most commonly prescribed classes of drugs for infectious diseases, but the rise of antibiotic-resistant bacteria has led to the development of new antibiotics and alternative therapies, such as antivirals and antifungals. Gilead Sciences is a biopharmaceutical company that develops and markets therapeutics for infectious diseases, including HIV/AIDS, hepatitis B and C, and influenza.
US Healthcare Reimbursement Market Analysis
The US healthcare reimbursement market is projected to grow from $2306 Bn in 2022 to $6440 Bn by 2030, registering a CAGR of 13.70% during the forecast period of 2022-30. Changes in healthcare policies and regulations, such as the Affordable Care Act (ACA) and the Medicare Access and CHIP Reauthorization Act (MACRA), are driving the adoption of new reimbursement models and payment strategies. Major health insurance companies in the US include UnitedHealth Group, Anthem, Aetna, Cigna, and Humana.
Italy Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Liver Disease Therapeutics market will reach a value of $831 Mn from $554 Mn in 2022, growing at a CAGR of 5.2% during 2022-2030. Liver Disease Therapeutics in Italy is dominated by a few domestic pharmaceutical companies such as Esaote, Chiesi Group, and Dompé. The Liver Disease Therapeutics market in Italy is segmented into different types of disease and different therapy types. Some of the major factors affecting the Italy Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
US Oral Care Market Analysis
The US Oral Care market was valued at $14.8 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022 to 2030 and will reach $20.5 Bn in 2030. One of the main reasons propelling the growth of this market is increased awareness and an aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Koninklijke Philips N.V., Colgate-Palmolive Company, GlaxoSmithKline plc, Procter & Gamble, Johnson & Johnson, Unilever plc, Ultradent Products, Inc., 3M Company, Hain Celestial Group (Jason Natural Products, Inc.), Church & Dwight Co., Supersmile, and CloSYS among others.
Canada Oral Care Market Analysis
The Canada Oral Care market was valued at $2.8 Bn in 2022 and is estimated to expand at a CAGR of 6.2% from 2022 to 2030 and will reach $4.5 Bn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, aging population. The market is segmented by type, drug and distribution channel. Some key players in this market are Sun Pharmaceutical Industries, Altima Dental, Dental Solutions, Millenium Dental , Dentalcorp, 123Dentist among others.
UK Oral Care Market Analysis
The UK Oral Care market was valued at $916 Mn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022 to 2030 and will reach $1273 Mn in 2030. One of the main reasons propelling the growth of this market is Rising Demand for Cosmetic Dentistry, Technological Advancements. The market is segmented by type, drug and distribution channel. Some key players in this market are Wisdom Toothbrushes, Curaprox UK, Oralieve, DenTek, Lush UltraDEX, Waken among others.